Preoperative Predictive Factors for Complete Cytoreduction and Survival Outcome in Epithelial Ovarian, Tubal, and Peritoneal Cancer After Neoadjuvant Chemotherapy-Reference-Cited by-同舟云学术

Preoperative Predictive Factors for Complete Cytoreduction and Survival Outcome in Epithelial Ovarian, Tubal, and Peritoneal Cancer After Neoadjuvant Chemotherapy

Published:2017-03 Issue:3 Volume:27 Page:420-429
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:International Journal of Gynecological Cancer

Author:

Baek Min-Hyun,Lee Shin-Wha,Park Jeong-Yeol,Rhim Chae Chun,Kim Dae-Yeon,Suh Dae-Shik,Kim Jong-Hyeok,Kim Yong-Man,Kim Young-Tak,Nam Joo-Hyun

Publisher

BMJ

Subject

Obstetrics and Gynecology,Oncology

Reference35 articles.

1. Cancer statistics, 2012

2. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012

3. Prediction of Cancer Incidence and Mortality in Korea, 2015

4. Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010

5. Neoadjuvant Chemotherapy Is the Better Treatment Option in Some Patients With Stage IIIc to IV Ovarian Cancer

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External validation of Standardized KELIM and platinum-resistant recurrence scores in patients with advanced epithelial ovarian cancer;Journal of Ovarian Research;2024-07-22

2. External validation of standardized KELIM and platinum resistant recurrence score in patients with advanced epithelial ovarian cancer;2022-12-08

3. Application of J‑Plasma in the excision of diaphragmatic lesions as part of complete cytoreduction in patients with advanced ovarian cancer;Molecular and Clinical Oncology;2022-05-18

4. Is there a correlation of positive peritoneal washing cytology during interval debulking surgery on the survival outcomes of ovarian cancer patients? A systematic review and meta-analysis of the literature;Journal of Gynecology Obstetrics and Human Reproduction;2022-01

5. Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer;Cancers;2021-02-05